An Incredible KLAS Triple-Award Win for AGFA HealthCare!
MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product for 2025.
"To receive a KLAS Award is one of the most notable wins for AGFA HealthCare, and a testament to the hard work we invest into our flagship platform. More importantly, it reflects the trust and recognition from our customers. Their success is our success, and to receive two such awards is simply breathtaking." - Nathalie McCaughley, President, AGFA HealthCare
The Best in KLAS report recognizes software and service providers who excel in supporting healthcare professionals and patient care. Based on extensive customer feedback and evaluations, these awards highlight AGFA HealthCare's unwavering commitment to innovation and excellence.
For 2025, AGFA HealthCare's Enterprise Imaging XERO® Viewer leads the Universal Viewer (Imaging) category for the second consecutive year, while Enterprise Imaging VNA secures top honors. These recognitions reaffirm the strength of AGFA's Enterprise Imaging Platform and its dedication to delivering value and support to healthcare providers worldwide. The award will be presented at the Best in KLAS Awards Ceremony at HIMSS, where Nathalie McCaughley will proudly represent #TeamAGFA.
KLAS CEO Adam Gale emphasizes the significance of these accolades:
"Congratulations to the 2025 winners of the Best in KLAS awards. Winning a Best in KLAS award signifies a commitment to delivering outstanding value and innovation to healthcare providers and patients alike. It is my hope that these awards inspire the winners and other companies to reach new heights."
Adding to this success, AGFA HealthCare is honored to receive the KLAS Most Improved Software Product for 2025. The award will be presented at the Best in KLAS Awards Ceremony at ViVE.
KLAS President Steve Low commends AGFA HealthCare's progress:
"Receiving the KLAS Most Improved Vendor recognition requires humility and unwavering dedication to improvement. I extend my heartfelt congratulations to AGFA HealthCare for achieving the accolade of 2025 Best in KLAS Most Improved Software Product. This award speaks to the improvements your customers have experienced this past year, and how they benefit both providers and the patients they care for."
McCaughley further reflects on this achievement:
"The Most Improved Software Product Award is a powerful validation of AGFA HealthCare's commitment to innovation and customer success. It highlights our role as a trusted partner, ensuring that our technology evolves to meet the needs of a rapidly advancing imaging landscape."
This recognition reinforces AGFA HealthCare's dedication to advancing Enterprise Imaging and delivering innovative solutions that empower healthcare providers. We deeply appreciate the trust and collaboration of our valued customers and partners as we continue to shape the future of medical imaging.
Join us at HIMSS25 to explore how AGFA HealthCare powers success in Enterprise Imaging. Attending the Annual Best in KLAS Awards Show? Look out for AGFA HealthCare as we celebrate our industry-leading achievements!
More information can be found in 2025 Best in KLAS: Software & Services Report. Visit the report for a complete view.
About AGFA HealthCare
At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channeling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.
About AGFA HealthCare XERO® Viewer
AGFA HealthCare's Enterprise Imaging XERO® Universal Viewer is a revolutionary solution that allows healthcare professionals to work seamlessly, regardless of location. With XERO® Universal Viewer, users can effortlessly capture and upload images from any location that has an internet connection. The platform enhances the overall viewing experience, clinical depth, collaboration, and sharing capabilities - all within a single, user-friendly streaming web viewer. AGFA HealthCare's continuous pursuit of excellence is reflected in its innovative solutions, such as the XERO® Universal Viewer, which empowers healthcare professionals to elevate their standards of care through advanced imaging technology.
About AGFA HealthCare VNA
Implementing Enterprise Imaging VNA is about more than solving your imaging data storage challenges. It's about providing image identification and capturing workflows that ensure that your metadata has excellent quality when creating a patient longitudinal view accessible within the EMR. It is also about planning your archiving needs with the future in mind and exploring your cloud storage options. It supports your corporate evolution, such as becoming part of a regional network, reducing IT complexity and cost. Simplify your IT landscape and enhance care collaboration with curated, good-quality multimedia image data - stored in one place.
That's life in flow. Follow us at HIMSS on: X | LinkedIn
Contact Information
Jessica Baldry
Global Marketing & Communications Manager, AGFA HealthCare
jessica.baldry@agfa.com
+44 7583 203971
Kara Clarke
Director of Marketing North America
kara.clarke@agfa.com
Viviane Dictus
Corporate Press Relations
viviane.dictus@agfa.com
+32 (0)3 444 8015
SOURCE: AGFA HealthCare
Related Images
View the original press release on ACCESS Newswire
AGFA HealthCare
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom